Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine

Abstract

A major risk associated with the acute treatment of severe hypertension is a reduction in cerebral blood flow (CBF) with ischemic injury to the central nervous system. The authors studied CBF before and after the acute treatment of severe hypertension (diastolic blood pressure > 115 mm Hg) with clonidine in 13 patients. One patient did not reach goal blood pressure (diastolic blood pressure 105 mm Hg or a decrease by 30 mm Hg) after clonidine alone. In the remaining 12 patients, oral clonidine reduced supine blood pressure from 201.7 ± 5.0 126.3 ± 2.1 mm Hg to 149.4 ± 5.3 96.8 ± 1.7 mm Hg over an average time period of 85 ± 7 minutes. Although mean CBF for the group did not change (72.6 ± 4.2 v 73.7 ± 3.5 mL/100 mg/min), a significant (>10%) change occurred in 9 of the 12 patients (5 increases and 4 reductions). The magnitude and direction of the change were dependent upon initial CBF ( r = −0.65, P < .05); patients with low pretreatment CBF experienced an increase, whereas those with high initial flow exhibited a decrease. No significant adverse effects were observed. These data confirm previous reports that clonidine is effective in the acute treatment of severe hypertension and demonstrate that its effects on CBF are determined by the pretreatment levels of flow.